Sub Heading

Clinical Trials Details

Randomized Phase III Trial of Pembrolizumab VS. Pembrolizumab/Cetuximab in Recurrent Or Metastatic Head and Neck Squamous Cell Carcinoma With Platinum Refractory Disease

IRB Protocol Number
A092205

Clinical Trial Categories

  • Head and Neck
Contact
Clinical Trials at 910-715-2200

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.